The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...

OCD Awareness Week is an international event that raises awareness about obsessive compulsive disorder (OCD). The week aims to educate people about OCD, reduce stigma, and help people get treatment.

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Glutamatergic medications are linked to significant symptom improvement in obsessive-compulsive and related disorders, a new ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...